Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Area of interest

Area of interest

Type 1 selected

Type

Guidance programme

Showing 1551 to 1600 of 2003

TitleReference numberPublishedLast updated
Ultrasound-guided foam sclerotherapy for varicose veinsIPG440
Percutaneous pulmonary valve implantation for right ventricular outflow tract dysfunctionIPG436
Autologous blood injection for plantar fasciitisIPG437
Autologous blood injection for tendinopathyIPG438
Deep dermal injection of non-absorbable gel polymer for HIV-related lipoatrophyIPG439
Tadalafil for the treatment of symptoms associated with benign prostatic hyperplasia (terminated appraisal)TA273
Vinflunine for the treatment of advanced or metastatic transitional cell carcinoma of the urothelial tractTA272
Ipilimumab for previously treated advanced (unresectable or metastatic) melanomaTA268
Decitabine for the treatment of acute myeloid leukaemia (terminated appraisal)TA270
Dronedarone for the treatment of non-permanent atrial fibrillationTA197
Physical activity: walking and cyclingPH41
Mannitol dry powder for inhalation for treating cystic fibrosisTA266
Ivabradine for treating chronic heart failureTA267
Laparoscopic gastric plication for the treatment of severe obesityIPG432
Percutaneous laser atherectomy as an adjunct to balloon angioplasty (with or without stenting) for peripheral arterial diseaseIPG433
Radiofrequency cold ablation for respiratory papillomatosisIPG434
Depth of anaesthesia monitors – Bispectral Index (BIS), E-Entropy and Narcotrend-Compact MDG6
Social and emotional wellbeing: early yearsPH40
Denosumab for the prevention of skeletal-related events in adults with bone metastases from solid tumoursTA265
Alteplase for treating acute ischaemic strokeTA264
Neutropenic sepsis: prevention and management in people with cancerCG151
SonoVue (sulphur hexafluoride microbubbles) – contrast agent for contrast-enhanced ultrasound imaging of the liverDG5
Mega Soft Patient Return Electrode for use during monopolar electrosurgeryMTG11
Bevacizumab in combination with capecitabine for the first-line treatment of metastatic breast cancerTA263
Rivaroxaban for the treatment of deep vein thrombosis and prevention of recurrent deep vein thrombosis and pulmonary embolismTA261
Endovascular stent insertion for intracranial atherosclerotic diseaseIPG429
Partial replacement of the meniscus of the knee using a biodegradable scaffoldIPG430
Sickle cell disease: managing acute painful episodes in hospitalCG143
Botulinum toxin type A for the prevention of headaches in adults with chronic migraineTA260
Lapatinib or trastuzumab in combination with an aromatase inhibitor for the first-line treatment of metastatic hormone receptor-positive breast cancer that overexpresses HER2TA257
Erlotinib for the first-line treatment of locally advanced or metastatic EGFR-TK mutation-positive non-small-cell lung cancerTA258
Percutaneous balloon cryoablation for pulmonary vein isolation in atrial fibrillationIPG427
Focal therapy using cryoablation for localised prostate cancerIPG423
Micropressure therapy for refractory Ménière's diseaseIPG426
Fingolimod for the treatment of highly active relapsing–remitting multiple sclerosisTA254
Incisionless otoplastyIPG422
Tocilizumab for the treatment of rheumatoid arthritisTA247
Cetuximab, bevacizumab and panitumumab for the treatment of metastatic colorectal cancer after first-line chemotherapyTA242
Rituximab for the first-line treatment of stage III-IV follicular lymphomaTA243
Apixaban for preventing venous thromboembolism after hip or knee replacement surgeryTA245
Breast reconstruction using lipomodelling after breast cancer treatmentIPG417
Bevacizumab and cetuximab for the treatment of metastatic colorectal cancerTA118
Epiretinal brachytherapy for wet age-related macular degenerationIPG415
Service user experience in adult mental health: improving the experience of care for people using adult NHS mental health servicesCG136
Tocilizumab for the treatment of systemic juvenile idiopathic arthritisTA238
Fulvestrant for the treatment of locally advanced or metastatic breast cancerTA239
Drainage, irrigation and fibrinolytic therapy (DRIFT) for post-haemorrhagic hydrocephalus in preterm infantsIPG412
Magnetic resonance image-guided transcutaneous focused ultrasound for uterine fibroidsIPG413
Single-port laparoscopic nephrectomyIPG414
Healthcare-associated infections: prevention and controlPH36

Results per page

  1. 10
  2. 25
  3. 50
  4. All